Molecular Characterization of Patients With Acute Myeloid Leukemia and the Impact of Clonal Evolution in the Response to Therapeutic Treatments
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This study aims to analyze patients with mutated FLT3 AML treated with specific therapy by means of molecular characterization methods, to identify the presence of clones and subclones at onset and to be able to follow their evolution during therapeutic treatment.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• FLT3 mutated
Locations
Other Locations
Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola
RECRUITING
Bologna
Contact Information
Primary
Emanuela Ottaviani, MD
emanuela.ottaviani@aosp.bo.it
0039 0512144055
Time Frame
Start Date: 2023-03-15
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 20
Related Therapeutic Areas
Sponsors
Leads: IRCCS Azienda Ospedaliero-Universitaria di Bologna